Wall Street Analysts Believe Zymeworks (ZYME) Could Rally 41.36%: Here's is How to Trade

Core Viewpoint - Zymeworks Inc. (ZYME) shares have increased by 10.1% in the past four weeks, closing at $14.46, with a potential upside of 41.4$20.44 [1] Price Targets - The mean estimate consists of eight short-term price targets with a standard deviation of $6.40, indicating variability among analysts; the lowest estimate is$12 (17% decline), while the highest is $30 (107.5% increase) [2][7] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [7] Earnings Estimates - Analysts are optimistic about ZYME's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 2.5%, with one estimate increasing and no negative revisions [10] Zacks Rank - ZYME holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside in the near term [11] Conclusion on Price Targets - While consensus price targets may not reliably indicate the extent of ZYME's potential gains, they can provide a useful guide for the direction of price movement [12]